REQUEST A DEMO
Total
USD $0.00
Search more companies

Toliddaru Pharmaceutical Company Public Joint Stock (Iran)

Main Activities: Pharmaceutical and Medicine Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Toliddaru Pharmaceutical Company Public Joint Stock Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Tolid Daru Company was established in 2005 and has started its activities in the field of manufacturing pharmaceutical and health products. Prior to the victory of the Revolution, this company with the TD brand was one of the leading pharmaceutical factories in the country, and after the victory of the Islamic Revolution, it has always been among the leading factories for the production and supply of medicine pharmaceutical company (private joint stock company). The products, manufactured by the company, cover a wide range of treatment groups such as cardiovascular, gastrointestinal, respiratory, skin, neurological, analgesic and antipyretic, systemic and topical antimicrobials, surface disinfectants and oral supplements.

Headquarters
Yadegar St, Saveh Highway
Tehran; Tehran; Postal Code: 1371616314

Contact Details: Purchase the Toliddaru Pharmaceutical Company Public Joint Stock report to view the information.

Website: http://www.toliddaru.ir

Basic Information
Total Employees:
Purchase the Toliddaru Pharmaceutical Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Toliddaru Pharmaceutical Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Toliddaru Pharmaceutical Company Public Joint Stock report to view the information.
Incorporation Date:
2005
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Vice Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
54%
Purchase this report to view the information.
1%
Company Performance
Financial values in the chart are available after Toliddaru Pharmaceutical Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
76.11%
Total operating revenue
71.72%
Operating profit (EBIT)
141.96%
EBITDA
130.39%
Net Profit (Loss) for the Period
339.31%
Total assets
54.94%
Total equity
82.67%
Operating Profit Margin (ROS)
7.25%
Net Profit Margin
8.76%
Return on Equity (ROE)
21.85%
Debt to Equity Ratio
-45.43%
Quick Ratio
0.1%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?